Analystreport

Fulcrum Therapeutics (NASDAQ: FULC) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report